2024
DOI: 10.1016/j.ijpharm.2024.124745
|View full text |Cite
|
Sign up to set email alerts
|

A nanotechnology driven effectual localized lung cancer targeting approaches using tyrosine kinases inhibitors: Recent progress, preclinical assessment, challenges, and future perspectives

Ankaj Kumar,
Klaudi K. Vaiphei,
Arvind Gulbake
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 98 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?